XRAY
28
2
TDC
80
4
AIV
72
2
UPS
60
9
LMT
34
2
RSG
71
3
PEP
48
6
CRM
67
2
ADSK
70
2
DOW
44
10
ROK
62
15
HSIC
56
5
VFC
53
5
SEE
56
6
CSCO
67
4
CL
58
2
MTB
67
2
MET
72
5
PG
56
5
PRGO
39
3
XRAY
28
2
TDC
80
4
AIV
72
2
UPS
60
9
LMT
34
2
RSG
71
3
PEP
48
6
CRM
67
2
ADSK
70
2
DOW
44
10
ROK
62
15
HSIC
56
5
VFC
53
5
SEE
56
6
CSCO
67
4
CL
58
2
MTB
67
2
MET
72
5
PG
56
5
PRGO
39
3
Financhill
Back

Apellis Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
48

APLS
Apellis Pharmaceuticals

Last Price:
30.76
Seasonality Move:
16.11%
Buy
61

BMRN
Biomarin Pharmaceutical

Last Price:
64.25
Seasonality Move:
12.47%
Sell
48
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $30.77. The Score for APLS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $64.26. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $30.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $64.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 59.23 Buy
Chaikin Money Flow: 2322513 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.9 - 29.12) Buy
Bollinger Bands (100): (28.55 - 38.61) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.96 Sell
Relative Strength Index (14 RSI): 38.59 Sell
Chaikin Money Flow: 518116 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.94 - 69.24) Sell
Bollinger Bands (100): (67.93 - 87.19) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.97 Buy
20-day SMA: 28.22 Buy
50-day SMA: 29.11 Buy
200-day SMA: 42.36 Sell
8-day EMA: 28.48 Buy
20-day EMA: 28.34 Buy
50-day EMA: 29.88 Buy
200-day EMA: 39.46 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.73 Buy
20-day SMA: 65.69 Sell
50-day SMA: 68.56 Sell
200-day SMA: 81.05 Sell
8-day EMA: 63.9 Buy
20-day EMA: 65.57 Sell
50-day EMA: 69.74 Sell
200-day EMA: 79.39 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.77 per share, and an increase next year of $0.81 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):